US Drug Recall Register

FDA Drug Recalls

2,661 recalls, newest first

Class III · Low risk Ongoing

Methotrexate Tablets

Reason Failed Tablet/Capsule Specifications: Tablets were observed to have an unsmooth surface with two tablets demonstrating illegible tablet identification and scoring.

West-Ward Columbus Inc D-0066-2024
Class I · High risk Ongoing

SANDIMMUNE Oral Solution

Reason Crystallization: bottles of Sandimmune Oral Solution were determined to contain crystals.

Novartis Pharmaceuticals Corp. NDC 0078-0110-22 D-1174-2023
Class I · High risk Ongoing

TheraBreath for Kids! Oral Rinse

Reason Microbial contamination of Non-Sterile Product; presence of yeast identified as Candida parapsilosis

Church & Dwight Inc D-0046-2024
Class II · Moderate risk Ongoing

octiq Lubricating Eye Drops

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1167-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1166-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1165-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1164-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1163-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1162-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1161-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1159-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1158-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1157-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1156-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1155-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1154-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1153-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1152-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1151-2023